Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parag Tolat

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal for Immunotherapy of Cancer|March 2, 2020
Salvage ipilimumab associated with a significant response in sarcomatoid renal cell carcinomaGemlyn George, Laura Schmidt, Parag Tolat, et al.
Cancer Journal (Sudbury, Mass.)|November 29, 2012
Current staging systems for pancreatic cancerBetsy L Appel, Parag Tolat, Douglas B Evans, et al.
The Journal of Trauma and Acute Care Surgery|November 22, 2013
Clinical utility of flat inferior vena cava by axial tomography in severely injured elderly patientsDavid Joseph Milia, Anahita Dua, Jasmeet Singh Paul, et al.
The Journal of Trauma|December 21, 2011
Minimal aortic injury after blunt trauma: selective nonoperative management is safeJasmeet S Paul, Todd Neideen, Sean Tutton, et al.
Journal of Surgical Oncology|June 7, 2016
Neoadjuvant treatment sequencing adds value to the care of patients with operable pancreatic cancerElliot A Asare, Douglas B Evans, Beth A Erickson, et al.
Journal of Oncology Practice|September 14, 2016
Evolution of the Management of Resectable Pancreatic CancerSusan Tsai, Beth A Erickson, Kulwinder Dua, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 19, 2013
Optimal management of the splenic vein at the time of venous resection for pancreatic cancer: importance of the inferior mesenteric veinCharles H C Pilgrim, Susan Tsai, Parag Tolat, et al.
Surgery|May 3, 2014
Arterial resection at the time of pancreatectomy for cancerKathleen K Christians, Charles H C Pilgrim, Susan Tsai, et al.
Journal of Surgical Oncology|October 22, 2016
Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated?Ashley N Krepline, Kathleen K Christians, Ben George, et al.
Journal of Gastrointestinal Oncology|August 12, 2015
Neoadjuvant therapy for localized pancreatic cancer: guiding principlesAmir Fathi, Kathleen K Christians, Ben George, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal for Immunotherapy of Cancer|March 2, 2020
Salvage ipilimumab associated with a significant response in sarcomatoid renal cell carcinomaGemlyn George, Laura Schmidt, Parag Tolat, et al.
Cancer Journal (Sudbury, Mass.)|November 29, 2012
Current staging systems for pancreatic cancerBetsy L Appel, Parag Tolat, Douglas B Evans, et al.
The Journal of Trauma and Acute Care Surgery|November 22, 2013
Clinical utility of flat inferior vena cava by axial tomography in severely injured elderly patientsDavid Joseph Milia, Anahita Dua, Jasmeet Singh Paul, et al.
The Journal of Trauma|December 21, 2011
Minimal aortic injury after blunt trauma: selective nonoperative management is safeJasmeet S Paul, Todd Neideen, Sean Tutton, et al.
Journal of Surgical Oncology|June 7, 2016
Neoadjuvant treatment sequencing adds value to the care of patients with operable pancreatic cancerElliot A Asare, Douglas B Evans, Beth A Erickson, et al.
Journal of Oncology Practice|September 14, 2016
Evolution of the Management of Resectable Pancreatic CancerSusan Tsai, Beth A Erickson, Kulwinder Dua, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 19, 2013
Optimal management of the splenic vein at the time of venous resection for pancreatic cancer: importance of the inferior mesenteric veinCharles H C Pilgrim, Susan Tsai, Parag Tolat, et al.
Surgery|May 3, 2014
Arterial resection at the time of pancreatectomy for cancerKathleen K Christians, Charles H C Pilgrim, Susan Tsai, et al.
Journal of Surgical Oncology|October 22, 2016
Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated?Ashley N Krepline, Kathleen K Christians, Ben George, et al.
Journal of Gastrointestinal Oncology|August 12, 2015
Neoadjuvant therapy for localized pancreatic cancer: guiding principlesAmir Fathi, Kathleen K Christians, Ben George, et al.
Pageof 2